This new report from Venture Planning Group provides analysis of the global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: C3
C4
Free Light Chains
Haptoglobin
IgA
IgE Specific
IgE Total
IgG
IgM
Immunofixation
Prealbumin
Protein Electrophoresis During the next decade, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Opportunities in the Global Immunoprotein Diagnostic Testing Market” is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., Europe, Japan; provides test volume and sales forecasts by country, market segment and individual test; compares features of leading analyzers; and profiles key competitors.
|